Increased incidence of admissions for anaphylaxis in Spain 1998-2011

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 7, 2015, Pages 880-883

  Tejedor Alonso, M A ^a,b   Moro Moro, M ^a   Mosquera Gonzalez M ^a   Rodriguez Alvarez, M ^a   Perez Fernandez E ^a   Latasa Zamalloa, P ^a   Farias Aquino, E ^a   Gil Prieto, R ^b   Gil De Miguel, A ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

admissions; anaphylaxis; children; food; increase

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; CHILD; FEMALE; FOOD; HOSPITAL ADMISSION; HOSPITAL PLANNING; HUMAN; ICD-9-CM; INCIDENCE; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPAIN; HEALTH SURVEY; HISTORY; HOSPITALIZATION; MIDDLE AGED;

ADULT; AGED; ANAPHYLAXIS; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; SPAIN;

EID: 84931564715     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12613     Document Type: Article

References (15)

1. Ministerio de Sanidad y Consumo. International Classification of Diseases 9th revision Clinical Modification. 2010. Available at: http://www.msces/estadEstudios/estadisticas/normalizacion/clasifEnferm/instrucNorma.htm Accessed March 22, 2011.
2. Encuesta Nacional de Salud. Madrid: Ministerio de Sanidad y Consumo. Direcciõn General de Salud Pública. 2001. Available at: http://www.msces/estadEstudios/estadisticas/encuestaNacional/encuestaNac2006/UtilizacionServiciosSanitariosPorcentajes.pdf 2006:10-12.
3. National Health Insurance. Deputy Directors Office of Administrative Coordination. National Information System for Hospital Data (CMBD) INSALUD hospitals 2001. Madrid, Spain. 2002. Available at: http://www.ingesamsc.es/ Accessed March 22, 2011 2002.
4. Rivero Cuadrado A,. The minimum data set in the NHS: early and ongoing developments. Rev Fuentes Estadísticas 2000 Available at: http://www.webcitation.org/query.php?url=http://www.fuentesestadisticas.com/Numero49/Paginas/18-19.htm&refdoi=10.1186/1471-2458-8-109. Accessed January 20, 2010;49:18-19.
5. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al., Second symposium on the definition and management of anaphylaxis: summary report-second National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397.
6. Harduar-Morano L, Simon MR, Watkins S, Blackmore C,. Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida. J Allergy Clin Immunol 2010; 126: 98-104.
7. Gupta R, Sheikh A, Strachan DP, Anderson HR,. Time trends in allergic disorders in the UK. Thorax 2007; 62: 91-96.
8. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB,. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007; 120: 878-884.
9. Lin RY, Anderson AS, Shah SN, Nurruzzaman F,. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Ann Allergy Asthma Immunol 2008; 101: 387-393.
10. Liew WK, Williamson E, Tang ML,. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009; 123: 434-442.
11. Beyer K, Morrow E, Li XM, Bardina L, Bannon GA, Burks AW, et al., Effects of cooking methods on peanut allergenicity. J Allergy Clin Immunol 2001; 107: 1077-1081.
12. Du Toit G, Katz Y, Sasieni P, Mesher D, Maleki SJ, Fisher HR, et al., Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 2008; 122: 984-991.
13. Vereda A, van Hage M, Ahlstedt S, Ibanez MD, Cuesta-Herranz J, van Odijk J, et al., Peanut allergy: clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol 2011; 127: 603-607.
14. Ma L, Danoff TM, Borish L,. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133: 1075-1083.
15. Walsh KE, Cutrona SL, Foy S, Baker MA, Forrow S, Shoaibi A, et al., Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. Pharmacoepidemiol Drug Saf 2013; 22: 1205-1213.